251 related items for PubMed ID: 12699440
1. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report.
Roche EF, Charmandari E, Dattani MT, Hindmarsh PC.
Clin Endocrinol (Oxf); 2003 May; 58(5):589-96. PubMed ID: 12699440
[Abstract] [Full Text] [Related]
2. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
3. Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Dötsch J, Rascher W, Dörr HG.
J Clin Endocrinol Metab; 2006 Dec; 91(12):4888-95. PubMed ID: 17003094
[Abstract] [Full Text] [Related]
4. Blood Pressure in a Large Cohort of Children and Adolescents With Classic Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency.
Bonfig W, Roehl FW, Riedl S, Dörr HG, Bettendorf M, Brämswig J, Schönau E, Riepe F, Hauffa B, Holl RW, Mohnike K, AQUAPE CAH Study Group.
Am J Hypertens; 2016 Feb; 29(2):266-72. PubMed ID: 26071487
[Abstract] [Full Text] [Related]
5. 24-hour ambulatory blood pressure profile in patients with congenital adrenal hyperplasia--a preliminary report.
de Silva KS, Kanumakala S, Brown JJ, Jones CL, Warne GL.
J Pediatr Endocrinol Metab; 2004 Aug; 17(8):1089-95. PubMed ID: 15379420
[Abstract] [Full Text] [Related]
6. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370
[Abstract] [Full Text] [Related]
7. Long-term prednisone versus hydrocortisone treatment in children with classic Congenital Adrenal Hyperplasia (CAH) and a brief review of the literature.
Ahmed SEAM, Soliman AT, Ramadan MA, Elawwa A, Abugabal AMS, Emam MHA, De Sanctis V.
Acta Biomed; 2019 Sep 06; 90(3):360-369. PubMed ID: 31580328
[Abstract] [Full Text] [Related]
8. Gender dichotomy in long term growth trajectories of children with 21-hydroxylase deficiency congenital adrenal hyperplasia.
Patel L, Chandrashekhar SR, Gemmell I, O'Shea E, Jones J, Banerjee I, Amin R, Clayton P.
Horm Res Paediatr; 2011 Sep 06; 75(3):206-12. PubMed ID: 20962509
[Abstract] [Full Text] [Related]
9. Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Körner A, Kiess W, Kratzsch J, Dörr HG.
Acta Paediatr; 2009 May 06; 98(5):885-91. PubMed ID: 19236311
[Abstract] [Full Text] [Related]
10. Sodium Chloride Supplementation Is Not Routinely Performed in the Majority of German and Austrian Infants with Classic Salt-Wasting Congenital Adrenal Hyperplasia and Has No Effect on Linear Growth and Hydrocortisone or Fludrocortisone Dose.
Bonfig W, Roehl F, Riedl S, Brämswig J, Richter-Unruh A, Fricke-Otto S, Hübner A, Bettendorf M, Schönau E, Dörr H, Holl RW, Mohnike K.
Horm Res Paediatr; 2018 May 06; 89(1):7-12. PubMed ID: 29073619
[Abstract] [Full Text] [Related]
11. Hypertension in children with congenital adrenal hyperplasia.
Maccabee-Ryaboy N, Thomas W, Kyllo J, Lteif A, Petryk A, Gonzalez-Bolanos MT, Hindmarsh PC, Sarafoglou K.
Clin Endocrinol (Oxf); 2016 Oct 06; 85(4):528-34. PubMed ID: 27105393
[Abstract] [Full Text] [Related]
12. Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience.
Hoepffner W, Kaufhold A, Willgerodt H, Keller E.
Horm Res; 2008 Oct 06; 70(1):42-50. PubMed ID: 18493149
[Abstract] [Full Text] [Related]
13. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
Manoli I, Kanaka-Gantenbein Ch, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C.
Clin Endocrinol (Oxf); 2002 Nov 06; 57(5):669-76. PubMed ID: 12390343
[Abstract] [Full Text] [Related]
14. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
Bonfig W, Schmidt H, Schwarz HP.
Horm Res Paediatr; 2011 Nov 06; 75(1):32-7. PubMed ID: 20714115
[Abstract] [Full Text] [Related]
15. Circadian blood pressure profiles and ambulatory arterial stiffness index in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency in relation to their genotypes.
Janus D, Wójcik M, Tyrawa K, Janeczko M, Bik-Multanowski M, Fijorek K, Drozdz D, Kwiatek K, Starzyk JB.
Neuro Endocrinol Lett; 2017 Dec 06; 38(7):509-518. PubMed ID: 29369603
[Abstract] [Full Text] [Related]
16. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.
Sellick J, Aldridge S, Thomas M, Cheetham T.
J Pediatr Endocrinol Metab; 2018 Sep 25; 31(9):1019-1022. PubMed ID: 30173205
[Abstract] [Full Text] [Related]
17. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP.
J Clin Endocrinol Metab; 2007 May 25; 92(5):1635-9. PubMed ID: 17299071
[Abstract] [Full Text] [Related]
18. Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients.
Van der Kamp HJ, Otten BJ, Buitenweg N, De Muinck Keizer-Schrama SM, Oostdijk W, Jansen M, Delemarre-de Waal HA, Vulsma T, Wit JM.
Arch Dis Child; 2002 Aug 25; 87(2):139-44. PubMed ID: 12138066
[Abstract] [Full Text] [Related]
19. 24-hour blood pressure profiles in children with congenital adrenal hyperplasia on two different hydrocortisone treatment regimens.
Liivak K, Tillmann V.
J Pediatr Endocrinol Metab; 2009 Jun 25; 22(6):511-7. PubMed ID: 19694198
[Abstract] [Full Text] [Related]
20. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
Charmandari E, Calis KA, Keil MF, Mohassel MR, Remaley A, Merke DP.
J Clin Endocrinol Metab; 2002 Jul 25; 87(7):3197-200. PubMed ID: 12107224
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
